Booth 16 NIR 2025 Conference

KAXG will be exhibiting at NIR 2025 at Rome, Italy during June 8-12. Come and visit us in the booth or join us for our Precourse which we will kick off on the 8th of June, 10:00-12:00.

This will be the 22nd time that NIR will be running and is considered to be the most prominent international conference dedicated to all aspects of NIR spectroscopy. The program will cover all aspects of near-infrared spectroscopy, spanning from methodological and technological advances in NIR spectroscopy (such as, e.g., NIR imaging and miniaturised devices) to applications in various fields (from agri-food analysis and quality control to clinical practice or pharmaceutical technology), and including chemometric modelling of spectroscopic data and hyperspectral images.

Our Precourse is Titled: Practical Sampling, NIR Spectroscopy and data analysis for PAT applications and will include expert insights from;

  • Brad Swarbrick, Managing Director and Cofounder of KAX Group, a leading provider of multivariate data analysis and model deployment platforms to industry, research and academia. Brad was part of the Pfizer global PAT group and has held many positions in industry and academia, including the Chief Operating Officer position for a worldwide software provider.
    Brad has over 25 years’ experience in the implementation of PAT into pharmaceutical and other industries and has expertise in the areas of chemometrics and vibrational spectroscopy. Brad has a PhD in Biospectroscopy from the University of Sydney and in the current pharmaceutical section editor of the Journal of Near Infrared Spectroscopy.
  • Steve Hammond is owner of Steve Hammond Consulting and has over 40 years’ experience in the deployment of PAT in pharmaceutical manufacturing, including implementation of representative sampling for PAT systems in pharmaceutical manufacturing equipment.  Steve was the director of the Process Analytical Sciences Group (PASG) at Pfizer for 30 years and has held roles with Expo Process Analytics amongst other roles on industry advisory boards.
    Steve now works as a consultant to industry helping organisations to optimise their approaches to sampling and PAT implementation in oral solid dose, biopharmaceutical and additive manufacturing operations.
  • Phil Doherty is CEO of Acuitis Process Analytical Technologies and has over 30 years’ experience in the development and implementation of sampling systems used for interfacing PAT instruments into pharmaceutical processes. Phil was part of the Pfizer global PAT group in Ireland and held positions at Expo Process Analytics including Managing Director and Chief Scientific Officer.
    Recently, Phil started Acuitis Process Analytical Technologies where he provides expert consulting, implementation and strategy development services related sampling, PAT and data analysis into regulated industries. Phil holds a bachelor of science with honours in chemistry and physiology and has a postgraduate diploma in business leadership and organisation.